PULCEBRO PLUS TABLETS belongs to the class of drugs called ‘mucolytic agents’ (cough/sputum thinner) primarily used to prevent and treat symptoms of chronic obstructive pulmonary disease (COPD) such as shortness of breath, coughing, or wheezing (whistling sound while breathing). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes).

PULCEBRO PLUS TABLETS is a combination of two drugs, namely: Acebrophylline (mucolytic and bronchodilator) and Acetylcysteine (mucolytic agent/sputum thinner). Acebrophylline belongs to the class of bronchodilators with additional mucolytic properties and works by relaxing muscles and widening the airways of the lungs. Acetylcysteine belongs to the class of mucolytic agents (cough/sputum thinner) that works by thinning and loosening phlegm (mucus) in the lungs, windpipe, and nose. PULCEBRO PLUS TABLETS breakdown the acid mucopolysaccharide fibers that make the mucus (sputum) thinner and less dense/viscous removing sputum efficiently by coughing. However, the viscosity of sputum remains low for as long as treatment is maintained. Together, they help to cough out easily and make breathing easier by opening airways.

Take PULCEBRO PLUS TABLETS as prescribed. Your doctor will recommend how often you take PULCEBRO PLUS TABLETS based on your medical condition. Some people may experience diarrhoea, nausea, vomiting, runny nose, dizziness, heartburn, stomach pain, skin rash, drowsiness, and cool and moist skin. Most of these side effects of PULCEBRO PLUS TABLETS do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to PULCEBRO PLUS TABLETS or any other medicines, please tell your doctor. PULCEBRO PLUS TABLETS is not recommended for children below 14 years of age. Drink plenty of fluids to thin mucus and lubricate your throat while taking PULCEBRO PLUS TABLETS . PULCEBRO PLUS TABLETS is not recommended for use during pregnancy. If you are breastfeeding, it is advised to inform your doctor before taking PULCEBRO PLUS TABLETS . Severe skin reactions such as Stevens-Johnson syndrome (a serious and rare disorder of skin and mucus membranes) or toxic epidermal necrolysis (skin blistering or skin peeling) have been rarely reported in some patients. However, if you notice any skin rash worsening with mucosal lesions or blisters, stop taking PULCEBRO PLUS TABLETS and contact your doctor immediately. Do not take PULCEBRO PLUS TABLETS if you have a heart rhythm disorder that causes fast heartbeats. Avoid taking PULCEBRO PLUS TABLETS if you have low blood pressure, irregular heartbeats, hemodynamic instability (unstable blood pressure), had a heart attack, or kidney or liver diseases. If you have hyperthyroidism (overactive thyroid), irregular heartbeats, viral infections, heart failure, asthma, high blood pressure, fits, gastric or duodenal ulcers, heart diseases, or kidney or liver insufficiency, inform your doctor before taking PULCEBRO PLUS TABLETS .

PULCEBRO PLUS TABLETS is a combination of two drugs, namely: Acebrophylline and Acetylcysteine. Acebrophylline belongs to the class of bronchodilators with additional mucolytic properties and works by relaxing muscles and widening the airways of the lungs. Acetylcysteine is a mucolytic agent (cough/sputum thinner) that works by thinning and loosening phlegm (mucus) in the lungs, windpipe, and nose. PULCEBRO PLUS TABLETS breakdown the acid mucopolysaccharide fibers that make the mucus (sputum) thinner and less dense/viscous removing sputum efficiently by coughing. However, the viscosity of sputum remains low for as long as treatment is maintained. Together, they help to cough out easily and make breathing easier by opening airways.

If you are allergic to PULCEBRO PLUS TABLETS or any other medicines, please tell your doctor. PULCEBRO PLUS TABLETS is not recommended for children below 14 years of age. Regular monitoring of potassium levels is recommended while taking PULCEBRO PLUS TABLETS as it may cause low potassium levels in the blood. PULCEBRO PLUS TABLETS is not recommended for use during pregnancy. If you are breastfeeding, it is advised to inform your doctor before taking PULCEBRO PLUS TABLETS . Severe skin reactions such as Stevens-Johnson syndrome (a serious and rare disorder of skin and mucus membranes) or toxic epidermal necrolysis (skin blistering or skin peeling) have been rarely reported in some patients. However, if you notice any skin rash worsening with mucosal lesions or blisters, stop taking PULCEBRO PLUS TABLETS and contact your doctor immediately. Do not take PULCEBRO PLUS TABLETS if you have heart rhythm disorder that causes fast heartbeats. Avoid taking PULCEBRO PLUS TABLETS if you have low blood pressure, irregular heartbeats, hemodynamic instability (unstable blood pressure), had a heart attack, or kidney or liver diseases. If you have hyperthyroidism (overactive thyroid), irregular heartbeats, viral infections, heart failure, asthma, high blood pressure, fits, gastric or duodenal ulcers, heart diseases, or kidney or liver insufficiency, inform your doctor before taking PULCEBRO PLUS TABLETS .

• Regular blood tests are recommended while taking PULCEBRO PLUS TABLETS to monitor the levels of PULCEBRO PLUS TABLETS and potassium in the blood.
• PULCEBRO PLUS TABLETS may affect the test results of ketones in urine and salicylate (like aspirin) in the blood. Therefore, inform your doctor that you are taking PULCEBRO PLUS TABLETS before undergoing any laboratory tests.
• PULCEBRO PLUS TABLETS does not relieve sudden asthma symptoms, so it is advised to carry a rescue inhaler always to treat sudden asthma symptoms.